Details of Drug

Details of Drug

 Drug General Information (ID: D1823)
  Drug Name
Iodine
  Drug Type Small molecule
  Drug Synonymous
7553-56-2|I|Iodine|Molecular iodine|Diiodine|Iodine crystals|Iodine solution|Iodine sublimed|Tincture iodine|Vistarin|Eranol|Iodio|Iode|Iosan superdip|Jood|Iodine-127|Iodine tincture|Iodine colloidal|Iodine Tincture USP|Ethanolic solution of iodine|Iodine ((127)I2)|Jod [German, Polish]|Iodum|I2|12190-71-5|UNII-9679TC07X4|MFCD00011355|Jod|CHEBI:17606|Iodine, crystalline|NSC-42355|9679TC07X4|Iodine Solution, Wijs|Actomar|Iodio [Italian]|Jod (GERMAN, POLISH)|Jood [Dutch]|IODE [French]|Caswell No. 501|diiodane|HSDB 34|Iodine (resublimed)|CCRIS 9223|Iodine [USP:JAN]|EINECS 231-442-4|NSC 42355|EPA Pesticide Chemical Code 046905|Jodosan|Tegodyne|iodine-iodide|iodonium iodide|Diatomic iodine|Iodine strong|Iodine mild|AI3-08544|Iodine,|Iodine, elemental|Iodine, resublimed|I2I|Cadex (TN)|Iodine, ACS reagent|Iodine Solution, 1N|IODINE-MOLECULE|Iodine lump, ultra dry|Iodine solution, 5 mM|Iodine (JP17/USP)|Iodine solution, 0.5 M|EC 231-442-4|Iodine, resublimed crystals|DSSTox_CID_14672|DSSTox_RID_79188|Iodine solution, 0.05 M|DSSTox_GSID_34672|Iodine Solution, 5%, Lugol|Iodine 0.1N Standard Solution|CHEMBL1201225|DTXSID7034672|Iodine, 99.99% metals basis|Iodine, AR, >=99.8%|Iodine, LR, >=99.5%|Iodine , LUGOL's Solution 5%|AMY39508|BCP31677|NSC42355|Iodine, 1.0N Standardized Solution|Tox21_301294|MFCD00164163|Iodine Solution, 0.02N (N/50)|Iodine, 0.01N Standardized Solution|AKOS015902439|Iodine spheres, ultra dry, -10 mesh|DB05382|Iodine, 99.999% trace metals basis|Iodine, SAJ first grade, >=99.0%|MCULE-3297948557|Iodine, >=99.99% trace metals basis|Iodine, USP, 99.8-100.5%|Iodine, JIS special grade, >=99.8%|Iodine, Vetec(TM) reagent grade, 99%|NCGC00257544-01|BP-21210|Iodine, ACS reagent, >=99.8%, solid|Iodine, ReagentPlus(R), >=99%, chips|CAS-7553-56-2|Iodine, purum p.a., >=99.5% (RT)|Diiodine;IODUM; Jood; Iode; Jod; LUGOL|Iodine, resublimed crystals, Puratronic(R)|FT-0627248|FT-0696506|I0604|C01382|D00108|Iodine, 1.0N Standardized Solution in Ethanol|Iodine, ReagentPlus(R), >=99.8% (titration)|Q2064483|Iodine, puriss., >=99.5% (RT), particles (round)|Iodine spheres, ultra dry, -10 mesh, 99.998% metals basis|Iodine, anhydrous, beads, -10 mesh, 99.999% trace metals basis|Iodine, ReagentPlus(R), 99.7% trace metals basis, beads, 1-3 mm|Iodide, Ion chromatography standard solution, Specpure, I- 1000g/ml|Iodine, 0.1N Standardized Solution in water, contain 1-2% Potassium iodide|Iodine Solution (0.02M in THF/pyridine/H2O 70:20:10), for DNA synthesis|Iodine Solution (0.05M in THF/H2O/pyridine 70:20:10), for DNA synthesis|Iodine, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.8-100.5%
    Click to Show/Hide
  Therapeutic Class Nutritional Supplements
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula I2
  InChI InChI=1S/I2/c1-2
  InChIKey PNDPGZBMCMUPRI-UHFFFAOYSA-N
  Canonical SMILES II
  External Link
Pubchem ID 807

Drug-Drug Interaction Network
  Sunburst Graph
AM003  Affected organization distribution
AM006  Pharmacodynamic additive effects
BM014  Interference of cell/tissue uptake
BM109  Increased risk of other adverse reactions (Unspecific)
  Relation Graph
 Full list of drugs interacting with Iodine
      Affected organization distribution
   Interference of cell/tissue uptake Drug Num:  2
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1822
 
Iodide I-123
 
I-
 
135300 
Moderate    Inter Info   
[1], [2], [3]
D0830
 
Iodide I-131
 
I-
 
167195 
Moderate    Inter Info   
[1], [2], [3]
      Pharmacodynamic additive effects
   Increased risk of other adverse reactions (Unspecific) Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0940
 
Lithium carbonate
 
CLi2O3
 
11125 
Moderate    Inter Info   
[4], [5], [6]
References
1 Cerner Multum, Inc. "Australian Product Information.".
2 Product Information. Sodium Iodide I-123 (sodium iodide I-123). GE Healthcare, Princeton, NJ.
3 Product Information. Visipaque (iodixanol). Nycomed Inc, Princeton, NJ.
4 Shopsin B, Shenkman L, Blum M, Hollander CS "Iodine and lithium-induced hypothyroidism. Documentation of synergism." Am J Med 55 (1973): 695-9. [PMID: 4749208]
5 Luby ED, Schwartz D, Rosenbaum H "Lithium-carbonate-induced myxedema." JAMA 218 (1971): 1298-9. [PMID: 5171179]
6 Wiener JD "Lithium carbonate-induced myxedema." JAMA 220 (1972): 587. [PMID: 4401588]